Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy
Clinical trial NCT04023708 · COMPLETED
Trial details
- NCT number
- NCT04023708
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-11
- Primary completion
- 2023-03-27
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.